Moleculent
Summary active Updated Apr 30, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
Moleculent is a Stockholm, Sweden-based life sciences technology company developing a functional profiling platform that maps cell-cell communication in human tissue using a proprietary Proximity Ligation Assay 12. The company launched publicly in June 2024 with a $26 million Series A led by ARCH Venture Partners 3. On April 30, 2026, Moleculent announced an additional $20 million round led by Rubicon Healthcare Partners, with participation from existing investors ARCH Venture Partners and Eir Ventures, to scale its Techstart Early Access Program and accelerate US commercial expansion 12. Co-founder and CEO Olle Ericsson leads the company; as part of the 2026 round, Ole Dahlberg, Managing Partner at Rubicon Healthcare Partners, joined the Board of Directors 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2024-06-11 | Series A | $26M | ARCH Venture Partners | Eir Ventures 3 |
| 2026-04-30 | Growth round | $20M | Rubicon Healthcare Partners | ARCH Venture Partners, Eir Ventures 12 |
What Investors Say
No independently sourced investor quotes found.
What Founders Say
“The market is telling us it’s ready. With Rubicon joining ARCH and Eir Ventures, we now have a syndicate of builders with successful track records of scaling life science companies.” — Olle Ericsson, Co-Founder and CEO, April 30, 2026 1.
Sources
-
BioSpace, “Moleculent Raises $20 Million to Scale its Functional Profiling Platform and Accelerate US Expansion,” April 30, 2026, accessed April 2026. https://www.biospace.com/press-releases/moleculent-raises-20-million-to-scale-its-functional-profiling-platform-and-accelerate-us-expansion↩↩↩↩↩
-
Contract Pharma, “Moleculent Raises $20M to Scale Functional Profiling Platform, Accelerate US Expansion,” April 30, 2026, accessed April 2026. https://www.contractpharma.com/breaking-news/moleculent-raises-20m-to-scale-functional-profiling-platform-accelerate-us-expansion/↩↩↩
-
BioSpace, “Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication,” June 11, 2024, accessed April 2026. https://www.biospace.com/moleculent-launches-with-26-million-series-a-financing-to-advance-the-spatial-mapping-of-cell-cell-communication↩↩